Compare BNR & AXIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BNR | AXIN |
|---|---|---|
| Founded | 2014 | 2025 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Medical Specialities | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 318.2M | 274.3M |
| IPO Year | 2019 | N/A |
| Metric | BNR | AXIN |
|---|---|---|
| Price | $28.78 | $10.11 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 11.9K | ★ 19.9K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $136.32 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.18 | $9.93 |
| 52 Week High | $41.72 | $10.15 |
| Indicator | BNR | AXIN |
|---|---|---|
| Relative Strength Index (RSI) | 49.74 | 51.96 |
| Support Level | $28.28 | $10.11 |
| Resistance Level | $34.26 | $10.13 |
| Average True Range (ATR) | 2.86 | 0.02 |
| MACD | -1.00 | -0.00 |
| Stochastic Oscillator | 13.37 | 60.00 |
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.
Axiom Intelligence Acquisition Corp 1 is a blank check company.